Given this, Q1 Revenue will be up around the $9m mark, which is huge considering FY20 Rev is $11.3m. Extrapolating this out and FY21 Rev will be huge, especially considering new revenue opportunities will come on board. Economies of scale will kick in, and NPAT rise nicely.
Of course we don't know when Covid will die down, but looks like it will be around for a while yet. In the meantime GSS should have a lot of their other products in the market.
Ann: Preliminary Final Report, page-5
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $129.3M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 57.0¢ | $11.43K | 20.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35124 | 57.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 15467 | 1 |
View Market Depth
| Last trade - 15.49pm 09/10/2024 (20 minute delay) ? |
| GSS (ASX) Chart |